Your browser doesn't support javascript.
COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.
Huang, Yiman; Su, Xiaoyou; Xiao, Weijun; Wang, Hao; Si, Mingyu; Wang, Wenjun; Gu, Xiaofen; Ma, Li; Li, Li; Zhang, Shaokai; Yang, Chunxia; Yu, Yanqin; Qiao, Youlin.
  • Huang Y; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Su X; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. suxiaoyou@hotmail.com.
  • Xiao W; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang H; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Si M; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang W; School of Nursing, Jining Medical University, Jining, Shandong, China.
  • Gu X; Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, China.
  • Ma L; Public Health School, Dalian Medical University, Dalian, China.
  • Li L; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Zhang S; Henan Cancer Hospital, Affiliate Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Yang C; Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Yu Y; School of Public Health, Department of Clinical Research, Baotou Medical College, Baotou, China.
  • Qiao Y; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South Panjiayuan, Chaoyang District, Beijing, China.
BMC Infect Dis ; 22(1): 153, 2022 Feb 14.
Article in English | MEDLINE | ID: covidwho-1686007
ABSTRACT

BACKGROUND:

COVID-19 vaccine has been available in China since the beginning of the 2021, however, certain numbers of people are reluctant for some reasons to vaccinate. The high vaccine coverage is crucial for controlling disease transmission, however, the vaccine hesitancy might be a barrier to the establishment of sufficient herd immunization. This study aims to investigate the prevalence of the COVID-19 vaccine hesitancy among different population groups, and explore common barriers and facilitators to vaccination decisions.

METHODS:

The current survey was performed among Chinese students, public health professionals, medical workers and general population from January to March 2021 from seven cities in China. The questionnaire contained sociodemographic information, concerns about infection with COVID-19, general vaccination behaviors and attitudes, the General Vaccine Hesitancy Scale, the COVID-19 Vaccine Hesitancy Scale and other potential factors. Univariate analysis was conducted by chi-squared test, and variables significant at P < 0.10 were then included in a multivariable regression model.

RESULTS:

The prevalence of COVID-19 vaccine hesitancy was 15.6% in our study, and 23.9% of students, 21.2% of the general population, 13.1% of medical workers, and 10.4% of public health professionals had vaccine hesitancy. The results of multivariate analysis indicated that participants who had received negative information of COVID-19 vaccine (OR 1.563, 95% CI 1.229-1.986) and who had doubts about the information source (OR 2.157, 95% CI 1.697-2.742) were more likely to have vaccine hesitancy. While those who needed transparent information about COVID-19 vaccine (OR 0.722, 95% CI 0.535-0.973) and who would get COVID-19 vaccine if doctors recommended (OR 0.176, 95% CI 0.132-0.234) were less likely to have COVID-19 vaccine hesitancy.

CONCLUSIONS:

Given recommendations from medical workers about vaccination can motivate people to accept COVID-19 vaccination, appropriate training in knowledge about vaccines and communication skills are necessary for them to increase public's willingness of vaccination. Reducing the spread of misinformation and disseminating facts in a timely and accurate way will likely reduce vaccine hesitancy. Moreover, to establish suitable communication strategies and information exchange platforms between the government and the public and a warning system on infodemic would be helpful to improve public's confidence in vaccination.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07111-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07111-0